Document is current
Any future updates will be listed below
-
Authors
Kwok, Charlie H. T.
Harding, Erika K.
Burma, Nicole E. https://orcid.org/0000-0001-8076-1798
Markovic, Tamara
Massaly, Nicolas
van den Hoogen, Nynke J. https://orcid.org/0000-0002-1731-2903
Stokes-Heck, Sierra https://orcid.org/0009-0005-0472-8212
Gambeta, Eder
Komarek, Kristina https://orcid.org/0000-0002-3139-3009
Yoon, Hye Jean https://orcid.org/0000-0002-3830-3678
Navis, Kathleen E.
McAllister, Brendan B. https://orcid.org/0000-0003-4135-3040
Canet-Pons, Julia
Fan, Churmy
Dalgarno, Rebecca
Gorobets, Evgueni
Papatzimas, James W. https://orcid.org/0000-0001-8944-1037
Zhang, Zizhen https://orcid.org/0000-0001-8069-3756
Kohro, Yuta https://orcid.org/0000-0002-3128-7388
Anderson, Connor L. https://orcid.org/0000-0001-8651-5221
Thompson, Roger J.
Derksen, Darren J. https://orcid.org/0000-0002-5945-6921
Morón, Jose A. https://orcid.org/0000-0003-3216-2488
Zamponi, Gerald W. https://orcid.org/0000-0002-0644-9066
Trang, Tuan https://orcid.org/0000-0003-3309-9492
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-173553, PJT-173553)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN06289-2019)
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 11 July 2024
First Online: 24 July 2024
Competing interests
: T.T., D.J.D., and R.J.T. are co-founders of AphioTx Inc. Patents have been granted for the use of probenecid in opioid withdrawal (T.T., N.E.B.). Patents are pending for EG-2183 and related compounds for use in opioid withdrawal (T.T., D.J.D., C.H.T.K., E.K.H., N.E.B., E.G., K.K., K.E.N., C.F., E.G., and J.W.P. Specific patent details are provided in the Disclosure of Potential Competing Interest. G.W.Z. is co-founder and CSO of Zymedyne Therapeutics. All other authors have declared that no conflict of interest exists.
